Increasing Viral Testing in the Emergency Department (InVITED)
This study is currently recruiting participants.
Verified July 2011 by Rhode Island Hospital
Sponsor:
Rhode Island Hospital
Collaborator:
Information provided by:
Rhode Island Hospital
ClinicalTrials.gov Identifier:
NCT01419899
First received: July 6, 2011
Last updated: August 16, 2011
Last verified: July 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine if a brief intervention delivered to emergency department patients increases the uptake of rapid HIV and hepatitis C testing in comparison to no brief intervention.
Condition | Intervention | Phase |
---|---|---|
Drug Use HIV Hepatitis C |
Behavioral: Brief motivational intervention |
Phase 2 Phase 3 |
Study Type: | Interventional |
Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Outcomes Assessor) Primary Purpose: Prevention |
Official Title: | Phase 2/3 Clinical Trial of the Effect of a Brief Intervention on Uptake of Rapid Testing for HIV and Hepatitis C Among Emergency Department Patients |
Resource links provided by NLM:
Further study details as provided by Rhode Island Hospital:
Primary Outcome Measures:
- The agreement of the participant to be tested for HIV and hepatitis C [ Time Frame: Within four hours of being consented into the study ] [ Designated as safety issue: No ]We will measure the acceptance of free rapid testing for HIV and hepatitis C among the intervention and control groups
Secondary Outcome Measures:
- Identifying risky sexual behaviors of study participants [ Time Frame: Within four hours of being consented into the study ] [ Designated as safety issue: No ]Identify factors that influence the relationship of BI and risk assessment vs. risk assessment alone on uptake of combined HIV and hepatitis C screening in the ED.
Estimated Enrollment: | 328 |
Study Start Date: | January 2011 |
Estimated Study Completion Date: | February 2012 |
Estimated Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Experimental: Brief Intervention
This arm of the study will receive an assessments survey followed by a brief intervention concerning the relationship between the participants use of drugs and/or sexual risk and rik for HIV and hepatitis C infections. Following the intervention the participants will be offered free rapid testing for HIV and hepatitis C.
|
Behavioral: Brief motivational intervention
A 20-30 minute motivational based discussion
|
No Intervention: Standard Care
This arm of the study will receive an assessments survey. Following the assessment the participants will be offered free rapid testing for HIV and hepatitis C.
|
Eligibility
Ages Eligible for Study: | 18 Years to 64 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Emergency department patient.
- Does not know HIV or hepatitis C status.
- Has an ASSIST V3 score that indicates recent illicit and/or prescription drug use.
- Fluency in English or Spanish.
Exclusion Criteria:
- Critically ill or injured.
- Homicidal and/or suicidal intention.
- Age < 18 years or > 64 years.
- Does not speak English or Spanish.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01419899
Locations
United States, Rhode Island | |
Rhode Island Hospital Emergency Department | Recruiting |
Providence, Rhode Island, United States, 02903 | |
Contact: Roland C Merchant, MD, ScD 401-444-5109 rmerchant@lifespan.org | |
Contact: Janette Baird, PhD 401-444-2976 jbaird@lifespan.org | |
Principal Investigator: Roland C Merchant, MD, ScD | |
Principal Investigator: Ted Nirenberg, PhD | |
Sub-Investigator: Janette Baird, PhD | |
Sub-Investigator: Michael J Mello, Md, MPH |
Sponsors and Collaborators
Rhode Island Hospital
Investigators
Principal Investigator: | Roland C Merchant, MD, ScD | Brown University |
Principal Investigator: | Ted D Nirenberg, PhD | Brown University |
More Information
No publications provided
Keywords provided by Rhode Island Hospital:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on March 03, 2013
No publications provided
Responsible Party: | Roland C Merchant, Department of Emergency Medicine, Rhode Island Hospital |
ClinicalTrials.gov Identifier: | NCT01419899 History of Changes |
Other Study ID Numbers: | 5R21DA28645-2 |
Study First Received: | July 6, 2011 |
Last Updated: | August 16, 2011 |
Health Authority: | United States: Institutional Review Board |
Keywords provided by Rhode Island Hospital:
Brief intervention Rapid testing |
Additional relevant MeSH terms:
Emergencies Hepatitis Hepatitis A Hepatitis C Disease Attributes Pathologic Processes Liver Diseases |
Digestive System Diseases Hepatitis, Viral, Human Virus Diseases Enterovirus Infections Picornaviridae Infections RNA Virus Infections Flaviviridae Infections |
ClinicalTrials.gov processed this record on March 03, 2013